Publication | Closed Access
Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis
80
Citations
25
References
2019
Year
Compared to untreated patients, TDF treatment reduces the risks of HCC, hepatic decompensation and death in CHB patients with cirrhosis at 5 years.
| Year | Citations | |
|---|---|---|
Page 1
Page 1